Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study.
Respir Res
; 23(1): 139, 2022 May 28.
Article
in En
| MEDLINE
| ID: mdl-35643466
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asbestosis
/
Idiopathic Pulmonary Fibrosis
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
Respir Res
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: